Physician profile
Misty Suri
NPI 1437238656
$1,214,192.70
in general payments reported to CMS, 2019-2025
36 companies · $621K in 2025
The $621K reported for 2025 was more than what 99% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $15K · 2021: $32K · 2022: $58K · 2023: $205K · 2024: $272K · 2025: $621K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $799K · Royalty Or License: $160K · Consulting Fee: $83K · Travel and Lodging: $44K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $799,419.76 |
| Royalty Or License | $159,618.90 |
| Consulting Fee | $83,184.33 |
| Travel and Lodging | $43,982.36 |
| Food and Beverage | $11,184.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,157,265.19 | 2019-2025 | Arthrex, Shoulder Implants Fibertak Knotless, Biologics Consumables Cartilage Repair Biocartilage |
| Anika Therapeutics, INC. | $38,019.12 | 2019-2025 | Tactoset, Integrity, Integrity Implant |
| Linvatec Corporation | $6,787.47 | 2022-2025 | Biobrace 23mm |
| Alon Medical Technology | $6,135.13 | 2019-2025 | |
| Stryker Corporation | $1,248.60 | 2019-2025 | Inspace, Alphavent, Crossfire |
| Vericel Corporation | $595.86 | 2019-2025 | Maci |
| Smith+Nephew, INC. | $426.01 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Pacira Therapeutics, INC. | $250.01 | 2019-2021 | |
| Bioventus LLC | $249.28 | 2024-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $238.00 | 2022-2023 | |
| Pacira Pharmaceuticals Incorporated | $225.38 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $222.19 | 2019-2022 | |
| Arthrosurface Incorporated | $204.79 | 2020 | |
| Ossur Americas, INC. | $197.07 | 2024-2025 | Unloader One X, Miami J |
| Tricoast Surgical Solutions LLC | $181.81 | 2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $174.58 | 2024-2025 | |
| Elite Orthopedics, LLC | $155.75 | 2025 | |
| Prime Surgical, LLC | $149.81 | 2023 | |
| Pylant Medical | $141.50 | 2024 | |
| Oak Med, INC. | $133.23 | 2024 | |
| Lifenet Health | $122.85 | 2022 | |
| Integra Lifesciences Corporation | $115.62 | 2019 | |
| Mallinckrodt Hospital Products INC. | $113.73 | 2020 | |
| Medacta USA, INC. | $104.69 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $102.70 | 2025 | |
| Parcus Medical, LLC | $100.30 | 2020 | |
| Medtronic USA, INC. | $95.28 | 2019 | |
| Djo, LLC | $87.33 | 2019 | |
| Hydrocision, INC. | $81.57 | 2025 | Tenjet |
| Saxum Surgical, INC. | $79.47 | 2024 | |
| Siemens Medical Solutions USA, INC. | $66.26 | 2024 | Acuson Origin Diagnostic Ultrasound System, Acuson Sequoia Diagnostic Ultrasound System, Acuson Freestyle Diagnostic Ultrasound System |
| Avanos Medical | $44.63 | 2024 | On-Q* Pump and Accessories |
| Titan Surgical Group, LLC | $39.92 | 2024 | |
| Breg, INC | $19.82 | 2022 | |
| Ferring Pharmaceuticals INC. | $17.75 | 2025 | Euflexxa |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Misty Suri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.